Market value added (MVA) is the difference between a firm fair value and its invested capital. MVA is a measure of the value a company has created in excess of the resources already committed to the enterprise.
MVA
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 Fair value of debt. See details »
2 Invested capital. See details »
Item | Description | The company |
---|---|---|
MVA | Cigna Group market (fair) value less invested capital. | Cigna Group MVA increased from 2021 to 2022 and from 2022 to 2023. |
MVA Spread Ratio
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | ||||||
Market value added (MVA)1 | 42,446) | 31,170) | 19,719) | 19,375) | 15,084) | |
Invested capital2 | 85,777) | 85,650) | 90,679) | 93,748) | 93,745) | |
Performance Ratio | ||||||
MVA spread ratio3 | 49.48% | 36.39% | 21.75% | 20.67% | 16.09% | |
Benchmarks | ||||||
MVA Spread Ratio, Competitors4 | ||||||
Abbott Laboratories | 257.59% | 230.60% | 266.78% | 300.18% | 202.12% | |
CVS Health Corp. | 8.29% | 26.73% | 49.51% | 20.97% | 20.89% | |
Elevance Health Inc. | 105.04% | 108.24% | 115.84% | 72.12% | 79.88% | |
Intuitive Surgical Inc. | 1,699.53% | 1,400.02% | 2,002.36% | 1,853.43% | 1,771.30% | |
Medtronic PLC | 88.43% | 93.80% | 163.10% | 107.64% | 113.36% | |
UnitedHealth Group Inc. | 192.81% | 214.27% | 265.59% | 189.93% | 187.47% |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 MVA. See details »
2 Invested capital. See details »
3 2023 Calculation
MVA spread ratio = 100 × MVA ÷ Invested capital
= 100 × 42,446 ÷ 85,777 = 49.48%
4 Click competitor name to see calculations.
Performance ratio | Description | The company |
---|---|---|
MVA spread ratio | The ratio of MVA to invested capital. It measures the efficiency with which investors’ capital investment has translated into a franchise value and into an aggregate net present value premium. | Cigna Group MVA spread ratio improved from 2021 to 2022 and from 2022 to 2023. |
MVA Margin
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | ||||||
Market value added (MVA)1 | 42,446) | 31,170) | 19,719) | 19,375) | 15,084) | |
Revenues from external customers | 194,099) | 179,361) | 172,529) | 159,157) | 152,176) | |
Performance Ratio | ||||||
MVA margin2 | 21.87% | 17.38% | 11.43% | 12.17% | 9.91% | |
Benchmarks | ||||||
MVA Margin, Competitors3 | ||||||
Abbott Laboratories | 383.09% | 323.76% | 384.46% | 523.78% | 368.47% | |
CVS Health Corp. | 3.14% | 10.28% | 22.27% | 10.70% | 11.44% | |
Elevance Health Inc. | 43.12% | 46.51% | 54.14% | 33.92% | 42.99% | |
Intuitive Surgical Inc. | 1,695.34% | 1,209.45% | 1,575.51% | 1,900.32% | 1,312.48% | |
Medtronic PLC | 199.61% | 205.92% | 391.27% | 264.99% | 269.43% | |
UnitedHealth Group Inc. | 95.85% | 109.81% | 130.39% | 96.88% | 91.49% |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 MVA. See details »
2 2023 Calculation
MVA margin = 100 × MVA ÷ Revenues from external customers
= 100 × 42,446 ÷ 194,099 = 21.87%
3 Click competitor name to see calculations.
Performance ratio | Description | The company |
---|---|---|
MVA margin | The ratio of MVA to sales. It measures how efficiently and prodigiously sales translate into franchise value. | Cigna Group MVA margin ratio improved from 2021 to 2022 and from 2022 to 2023. |